• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在寻求受孕的女性中,于保留子宫手术前短期使用relugolix治疗快速生长的子宫肌瘤:两例病例报告。

Short-term relugolix use for rapidly growing uterine fibroids before uterus-preserving surgery in women seeking to conceive: Two case reports.

作者信息

Ishikawa Hiroshi, Yao Erika, Kaneko Meika, Ota Masayuki, Takada Akiyo, Koga Kaori

机构信息

Department of Obstetrics and Gynecology, Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan.

出版信息

J Obstet Gynaecol Res. 2025 May;51(5):e16312. doi: 10.1111/jog.16312.

DOI:10.1111/jog.16312
PMID:40338039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12058349/
Abstract

Large uterine fibroids that grow rapidly over a short period should be differentiated from uterine leiomyosarcoma, and their treatment remains controversial in women seeking to conceive. Here, we report two cases of uterine fibroids treated with short-term relugolix administration followed by myomectomy. Needle biopsy specimens obtained before relugolix administration showed no malignancy, and significant tumor shrinkage was observed following treatment. Both patients subsequently underwent myomectomy. One patient achieved a live birth 14 months after myomectomy, whereas the other experienced improvement in severe anemia, allowing her to prepare for pregnancy. Histological examination after relugolix administration revealed atrophic changes in spindle cells within the fibroids, characterized by nuclear crowding and decreased immunoreactivity for desmin and α-smooth muscle actin. The significant fibroid shrinkage observed after the short-term administration of relugolix provided a rationale for myomectomy, improved anemia, and facilitated appropriate uterine reconstruction, ensuring structural integrity for future pregnancies in women of reproductive age.

摘要

短期内迅速生长的大型子宫肌瘤应与子宫平滑肌肉瘤相鉴别,对于有生育需求的女性,其治疗方案仍存在争议。在此,我们报告两例子宫肌瘤患者,先接受短期瑞卢戈利治疗,随后进行肌瘤切除术。在给予瑞卢戈利之前获取的穿刺活检标本未显示恶性特征,治疗后观察到肿瘤显著缩小。两名患者随后均接受了肌瘤切除术。一名患者在肌瘤切除术后14个月成功分娩,而另一名患者的严重贫血状况得到改善,使其能够为妊娠做准备。给予瑞卢戈利后的组织学检查显示肌瘤内梭形细胞出现萎缩性改变,其特征为核拥挤以及结蛋白和α平滑肌肌动蛋白的免疫反应性降低。短期给予瑞卢戈利后观察到的肌瘤显著缩小为肌瘤切除术提供了理论依据,改善了贫血状况,并有助于进行适当的子宫重建,确保育龄期女性未来妊娠时子宫结构的完整性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/12058349/5bc71ee3f1ea/JOG-51-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/12058349/bc039dda3915/JOG-51-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/12058349/32e182d8d338/JOG-51-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/12058349/5bc71ee3f1ea/JOG-51-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/12058349/bc039dda3915/JOG-51-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/12058349/32e182d8d338/JOG-51-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/12058349/5bc71ee3f1ea/JOG-51-0-g001.jpg

相似文献

1
Short-term relugolix use for rapidly growing uterine fibroids before uterus-preserving surgery in women seeking to conceive: Two case reports.在寻求受孕的女性中,于保留子宫手术前短期使用relugolix治疗快速生长的子宫肌瘤:两例病例报告。
J Obstet Gynaecol Res. 2025 May;51(5):e16312. doi: 10.1111/jog.16312.
2
The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).在绝经前妇女中,与亮丙瑞林相比,relugolix 用于腹腔镜子宫肌瘤剔除术前治疗的有效性:一项随机对照研究方案(MyLacR 研究)。
Trials. 2024 May 24;25(1):343. doi: 10.1186/s13063-024-08170-1.
3
Surgical myomectomy followed by oral Myfembree vs standard of care (SOUL trial): Study protocol for a randomized control trial.《经手术剔除子宫肌瘤后口服 Myfembree 与标准治疗(SOUL 试验)的比较:一项随机对照试验研究方案》
PLoS One. 2024 Jul 2;19(7):e0306053. doi: 10.1371/journal.pone.0306053. eCollection 2024.
4
The management of uterine fibroids in women with otherwise unexplained infertility.患有不明原因不孕症的女性子宫肌瘤的管理。
J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2.
5
Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.雷洛昔芬联合治疗有症状的子宫肌瘤的黑人/非裔美国女性:LIBERTY 长期扩展研究。
Am J Obstet Gynecol. 2024 Feb;230(2):237.e1-237.e11. doi: 10.1016/j.ajog.2023.10.030. Epub 2023 Oct 18.
6
Uterine Fibroid in a 16-Year-Old Adolescent Managed with a Fertility-Sparing Approach: A Case Report and Review of the Literature.16 岁青少年的子宫肌瘤采用保留生育力方法治疗:病例报告及文献复习。
J Pediatr Adolesc Gynecol. 2021 Jun;34(3):427-431. doi: 10.1016/j.jpag.2020.12.016. Epub 2021 Feb 13.
7
Thinking in context: Fibroids-to-uterine volume ratio in pre-surgical fertility evaluation for intramural fibroids.上下文思维:子宫肌瘤术前生育评估中子宫肌瘤与子宫体积比。
Eur J Obstet Gynecol Reprod Biol. 2024 Oct;301:194-200. doi: 10.1016/j.ejogrb.2024.08.024. Epub 2024 Aug 13.
8
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.用瑞戈非尼联合疗法治疗子宫肌瘤症状。
N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283.
9
Relugolix for the treatment of uterine fibroids.瑞戈非尼用于治疗子宫肌瘤。
Expert Opin Pharmacother. 2020 Oct;21(14):1667-1674. doi: 10.1080/14656566.2020.1787988. Epub 2020 Jul 17.
10
The management of uterine leiomyomas.子宫平滑肌瘤的管理
J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8.

本文引用的文献

1
Oncological outcomes of unexpected uterine leiomyosarcoma: A single-center retrospective analysis of 5528 consecutive hysterectomies.意外子宫平滑肌肉瘤的肿瘤学结局:5528 例连续子宫切除术的单中心回顾性分析。
J Surg Oncol. 2024 Mar;129(3):517-522. doi: 10.1002/jso.27509. Epub 2023 Nov 16.
2
Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment.低度子宫平滑肌肉瘤对激素治疗高度敏感。
Clin Cancer Res. 2023 Nov 14;29(22):4679-4684. doi: 10.1158/1078-0432.CCR-23-0692.
3
MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement.
MRI 评估子宫肿块发生平滑肌肉瘤的风险:共识声明。
Radiology. 2023 Feb;306(2):e211658. doi: 10.1148/radiol.211658. Epub 2022 Oct 4.
4
Short-term administration of oral relugolix before single-port laparoscopic-assisted vaginal hysterectomy for symptomatic uterine myomas: A retrospective comparative study with leuprorelin injection.短期口服瑞戈非尼在单孔腹腔镜辅助阴式子宫切除术治疗症状性子宫肌瘤中的应用:与亮丙瑞林注射的回顾性比较研究。
J Obstet Gynaecol Res. 2022 Jul;48(7):1921-1929. doi: 10.1111/jog.15269. Epub 2022 Apr 23.
5
Role of transvaginal ultrasound-guided biopsy in gynecology.经阴道超声引导下活检在妇科中的应用。
Int J Gynecol Cancer. 2020 Jan;30(1):128-132. doi: 10.1136/ijgc-2019-000734. Epub 2019 Oct 23.
6
Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.瑞戈非尼,一种新型的口服促性腺激素释放激素拮抗剂,治疗与子宫肌瘤相关的疼痛症状:日本女性的一项随机、安慰剂对照、3 期研究。
Fertil Steril. 2019 Nov;112(5):922-929.e2. doi: 10.1016/j.fertnstert.2019.07.013. Epub 2019 Oct 6.
7
Hormonal therapy in uterine sarcomas.子宫肉瘤的激素治疗。
Cancer Med. 2019 Apr;8(4):1339-1349. doi: 10.1002/cam4.2044. Epub 2019 Mar 21.
8
Uterine leiomyosarcoma: A review of the literature and update on management options.子宫平滑肌肉瘤:文献回顾与治疗选择的更新。
Gynecol Oncol. 2018 Dec;151(3):562-572. doi: 10.1016/j.ygyno.2018.09.010. Epub 2018 Sep 21.
9
Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging.对63例在T2加权磁共振成像上呈高信号强度的子宫肿瘤进行术前超声引导下针吸活检。
Int J Gynecol Cancer. 2014 Jul;24(6):1042-7. doi: 10.1097/IGC.0000000000000189.
10
Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.促性腺激素释放激素激动剂敏感型和耐药型子宫肌瘤中雌激素受体-α、孕激素受体和钙调蛋白表达的比较
Obstet Gynecol Sci. 2014 Mar;57(2):144-50. doi: 10.5468/ogs.2014.57.2.144. Epub 2014 Mar 15.